Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Soluble epoxide hydrolase (sEH) is a bifunctional enzyme that regulates the levels of bioactive lipids such as epoxyeicosatrienoic acids (EETs). It is involved in various physiological processes, including vascular tone, inflammation, pain perception, and cholesterol metabolism. Inhibition of sEH is being explored as a therapeutic strategy for hypertension, inflammation-related diseases, neuropathic pain, cardiovascular protection, metabolic disorders, and neurodegenerative diseases.
Inhibition of sEH stabilizes beneficial lipid mediators like EETs, impacting vascular tone, inflammation, pain, and cholesterol metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Soluble Epoxide Hydrolase (sEH).